Robin proposes retinal disease experiments and analyzes lab data
FutureHouse used Robin to connect literature research, experiment planning and analysis for dry age-related macular degeneration. Human researchers ran the lab work; the system proposed follow-up candidates from the results.
futurehouse.orgWhat happened
FutureHouse reports identifying ripasudil as a therapeutic candidate supported by laboratory experiments.
Reported by FutureHouse research teamHow the agent did it
- Use Crow and Falcon to research a therapeutic hypothesis and candidate molecules.
- Have human researchers run the proposed experiments and supply the data.
- Use Finch to analyze results and feed those findings into further experimental proposals.
Where a person stepped in
Human scientists performed physical experiments. The reported results are preclinical and do not establish a treatment for patients.
A person approved each step before the agent continued.
More details
About this account
Robin coordinated research and analysis agents across successive hypothesis and experiment cycles.
Primary research account, originally posted in May 2025 and updated for publication in May 2026. Clinical efficacy is not claimed here.
Credit: FutureHouse research team
Added 14 Oct 2026
Source published 19 May 2026
Source checked 14 Oct 2026
Tools and topics
Robin · Crow · Falcon · Finch
Research · Sources
Editorial completeness: 100/100. Measures documented fields, not agent performance or verified outcomes.
Prompt to try
Editorial adaptation, not the source author’s exact prompt. Replace bracketed inputs and review tool permissions first.
For [research question], review the supplied literature and summarize candidate hypotheses with citations and contradictory evidence. Propose an analysis plan for the provided data. Keep recommendations separate from results and stop before laboratory execution or clinical advice.